Logo image
A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration
Journal article   Open access   Peer reviewed

A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration

Heather A Stockman, James D Borchardt, Karen M Gehrs, Richard J H Smith, Giuliana Silvestri, Stephen R Russell, Caroline C W Klaver, Irene Barbazetto, Stanley Chang, Lawrence A Yannuzzi, …
Proceedings of the National Academy of Sciences - PNAS, Vol.102(20), pp.7227-7232
05/17/2005
DOI: 10.1073/pnas.0501536102
PMCID: PMC1088171
PMID: 15870199
url
https://doi.org/10.1073/pnas.0501536102View
Published (Version of record) Open Access

Abstract

Age-related macular degeneration (AMD) is the most frequent cause of irreversible blindness in the elderly in developed countries. Our previous studies implicated activation of complement in the formation of drusen, the hallmark lesion of AMD. Here, we show that factor H (HF1), the major inhibitor of the alternative complement pathway, accumulates within drusen and is synthesized by the retinal pigmented epithelium. Because previous linkage analyses identified chromosome 1q25-32, which harbors the factor H gene (HF1/CFH), as an AMD susceptibility locus, we analyzed HF1 for genetic variation in two independent cohorts comprised of approximately 900 AMD cases and 400 matched controls. We found association of eight common HF1 SNPs with AMD; two common missense variants exhibit highly significant associations (I62V, chi2 = 26.1 and P = 3.2 x 10(-7) and Y402H, chi2 = 54.4 and P = 1.6 x 10(-13)). Haplotype analysis reveals that multiple HF1 variants confer elevated or reduced risk of AMD. One common at-risk haplotype is present at a frequency of 50% in AMD cases and 29% in controls [odds ratio (OR) = 2.46, 95% confidence interval (1.95-3.11)]. Homozygotes for this haplotype account for 24% of cases and 8% of controls [OR = 3.51, 95% confidence interval (2.13-5.78)]. Several protective haplotypes are also identified (OR = 0.44-0.55), further implicating HF1 function in the pathogenetic mechanisms underlying AMD. We propose that genetic variation in a regulator of the alternative complement pathway, when combined with a triggering event, such as infection, underlie a major proportion of AMD in the human population.
Immunohistochemistry Humans Middle Aged Risk Factors European Continental Ancestry Group Genotype Mutation, Missense - genetics Genetic Variation Haplotypes - genetics Macular Degeneration - genetics DNA Mutational Analysis Aged, 80 and over Pigment Epithelium of Eye - pathology Aged Polymorphism, Single Nucleotide Gene Components Complement Factor H - genetics Odds Ratio Macular Degeneration - pathology

Details

Metrics

Logo image